Ethics declarations Conflict of interest Mette JF Nielsen, Helene H Hansen Duus, Katrine Kirkeby, Britt W Lauenborg, Benjamin Low and Louise Witten are employees and stockholders of Novo Nordisk A/S
Patients with clinically confirmed deficiencies may begin with weekly injections and then transition to a maintenance schedule
In contrast to small-molecule compounds, peptide drugs demonstrate pharmacokinetic characteristics of short elimination half-life and poor metabolic stability in vivo
DSIP Side Effects & Safety Older human trials and reviews report that DSIP appeared well tolerated at the doses tested, with transient effects such as mild headache, nausea, and dizziness in some subjects
Sikiric et al., 2018), BPC 157 has been shown to inhibit and counteract uncontrolled cell proliferation (Ki-67 overproduction counteracted) and increased expression of VEGF and subsequent signaling pathways (Radeljak et al., 2004